Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
Cell of origin role in cancer stem cell and GBM phenotype

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.04.16
Views: 2229

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA

Dr Luis Parada talks with ecancertv at AACR 2016 about his research into the origins of cancer.

Rather than the threat of any cell spontaneously becoming cancerous, Dr Parada reports that only stem or progenitor cells have the potential to initialise oncogenesis. 

Using the example of his adjacent research into neurofibromatosis, he describes the need to identify and target cancer stem cells to assure full remission.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation